Metraipolis › archive › dc_b8b7fcb44cb5
Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses — Europe PMC PMID:42693308
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42693308
- DOI
- 10.1186/s43556-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T02:59:30.300Z
- SHA-256 of the archived text
e93a6c5fea9e6fde34f3a09334e21a48a6a13264c545289b5b99aa351f02f17e- Stable URL of this page
https://metraipolis.com/documento/dc_b8b7fcb44cb5
How to cite
Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses — Europe PMC PMID:42693308 — Europe PMC (en), https://europepmc.org/article/MED/42693308 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b8b7fcb44cb5 (Metraipolis archive dc_b8b7fcb44cb5, sha256 e93a6c5fea9e6fde34f3a09334e21a48a6a13264c545289b5b99aa351f02f17e)
BibTeX
@misc{dcb8b7fcb44cb5,
title = {Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses — Europe PMC PMID:42693308},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42693308},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b8b7fcb44cb5; sha256 e93a6c5fea9e6fde34f3a09334e21a48a6a13264c545289b5b99aa351f02f17e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42693308. Agents can read the archived copy with the MCP tool read_document.